Highlights

  • Essential medicines to cost slightly more from April 1
  • Drug pricing regulator announced annual change of 0.0055% increase in price
  • Change in price applicable only to medicines that come under National List of Essential Medicines

Latest news

Palestinians say six killed in Israeli West Bank operations

Palestinians say six killed in Israeli West Bank operations

Around 70 Hindu pilgrims arrive in Pak from India to perform religious rituals at Katas Raj temples

Around 70 Hindu pilgrims arrive in Pak from India to perform religious rituals at Katas Raj temples

Delhi Elections: MCD passes proposal to release Rs 25.35 crore for preparations

Delhi Elections: MCD passes proposal to release Rs 25.35 crore for preparations

Global stocks struggle amid inflation, economic fears: December 19, 2024 analysis

Global stocks struggle amid inflation, economic fears: December 19, 2024 analysis

Union Home Minister Amit Shah reviews J&K security situation

Union Home Minister Amit Shah reviews J&K security situation

Mysterious 'dinga dinga' illness causing body shaking affects 300 in Uganda

Mysterious 'dinga dinga' illness causing body shaking affects 300 in Uganda

Putin ready to meet Trump 'anytime' to talk Ukraine deal

Putin ready to meet Trump 'anytime' to talk Ukraine deal

Champions Trophy 2025: India to play their matches at neutral venue

Champions Trophy 2025: India to play their matches at neutral venue

Minuscule rise in cost of essential medicines amid pharma industry's push for 10% hike

The drug pricing regulator announced an annual change of 0.0055% increase in prices of drugs including paracetamol, antibiotics such as azithromycin used to treat bacterial infections, anti-anaemia medicines, vitamins, and minerals

Minuscule rise in cost of essential medicines amid pharma industry's push for 10% hike

Essential medicines including painkillers, antibiotics, and anti-infectives are set to see a slight increase of 0.00055% in their prices from April 1. However, as per The Economic Times, a lobby group that represents more than 1,000 Indian drug makers urged the government to allow prices of all scheduled formulations to be increased by 10% with immediate effect. It had also sought a 20% increase in the prices of non-scheduled drugs.

The drug pricing regulator announced an annual change of 0.0055% increase in prices of drugs in line with the annual change in the wholesale price Index. The change in prices is however applicable only to the medicines that come under the National List of Essential Medicines which cover more than 800 drugs.

"Based on the WPI data provided by the office of the Economic Advisor, Department of Industry and Internal trade Ministry of Commerce and Industry, the annual change in WPI works out as (+) 0.00551% during the calendar year 2023 over the corresponding period in 2022," said the notice by the National Pharmaceutical Pricing Authority (NPPA)

The Economic Times quoted pharma industry insider and mentioned that this meagre price rise will not be enough to cheer the sector especially after two massive hikes of 12% and 10% in prices last year and 2022.

Meanwhile, an executive associate with the NGO told the publication that this will be a good move in the interest of maintaining the affordability of these drugs.

"Drastic hikes distort price controls. After witnessing two massive hikes back to back, this will be a good move in the interest of maintaining the affordability of these drugs," the executive told The Economic Times

Medicine cost rise

The list of essential medicines includes drugs like paracetamol, antibiotics such as azithromycin used to treat bacterial infections, anti-anaemia medicines, vitamins, and minerals. Some drugs used for treating moderately to severely ill Covid-19 patients and steroids are also on the list.

Also Read: From April, commonly used medications will cost 12% more

Price changes in medicines are allowed once a year and the pharma industry has been demanding a substantial increase in prices as it has been battling rising input costs.

The Economic Times report quoted Industry Experts and said that over the last few years, prices of some key active pharmaceutical ingredients have increased between 15% and 130%, with the price of paracetamol jumping 130% and that of excipients increasing 18-262%.

Glycerine and Propylene Glycol which is used in every liquid preparation including syrups, oral drops, and sterile preparations have become costlier by 263% and 83%, respectively. Similarly, the prices of intermediates have grown between 11% and 175%.



ADVERTISEMENT

Up Next

Minuscule rise in cost of essential medicines amid pharma industry's push for 10% hike

Minuscule rise in cost of essential medicines amid pharma industry's push for 10% hike

India's electric vehicle market to reach Rs 20 lakh crore by 2030, says Nitin Gadkari

India's electric vehicle market to reach Rs 20 lakh crore by 2030, says Nitin Gadkari

Mallya Calls for Justice Over Excess Debt Recovery and Legal Inconsistencies

Mallya Calls for Justice Over Excess Debt Recovery and Legal Inconsistencies

UK PM Keir Starmer hosts Indian business chiefs to boost investments

UK PM Keir Starmer hosts Indian business chiefs to boost investments

Bangladesh Government Plans to Renegotiate Power Deal with Adani Power, Citing Unfair Terms

Bangladesh Government Plans to Renegotiate Power Deal with Adani Power, Citing Unfair Terms

New Zealand falls into recession with abrupt economic slowdown

New Zealand falls into recession with abrupt economic slowdown

ADVERTISEMENT

editorji-whatsApp

More videos

Dollar Pushes Indian Rupee to Record Low of 85, Fed's Policy Outlook in Focus

Dollar Pushes Indian Rupee to Record Low of 85, Fed's Policy Outlook in Focus

Oil Prices Rally on Inventory Drop, Market Awaits Fed Projections

Oil Prices Rally on Inventory Drop, Market Awaits Fed Projections

SEBI Expands UPSI Definition, Strengthens ESG and Governance Frameworks

SEBI Expands UPSI Definition, Strengthens ESG and Governance Frameworks

Gold Imports surge in November: Commerce Ministry examining data for any calculation error

Gold Imports surge in November: Commerce Ministry examining data for any calculation error

Indian Stock Market: Mixed Sectoral Performance Amid IPO Highlights

Indian Stock Market: Mixed Sectoral Performance Amid IPO Highlights

Parliamentary Panel bats for legal guarantee of MSP to protect farmers' interests

Parliamentary Panel bats for legal guarantee of MSP to protect farmers' interests

Bihar fully prepared to create robust business ecosystem, investment safe: Dy CM Samrat Choudhary

Bihar fully prepared to create robust business ecosystem, investment safe: Dy CM Samrat Choudhary

"If they tax us, we tax them...," Trump Signals Tough Trade Stance; Reciprocal Tariffs on India

"If they tax us, we tax them...," Trump Signals Tough Trade Stance; Reciprocal Tariffs on India

Top 5 Losers of NIFTY 50: A Day of Decline for Leading Stocks

Top 5 Losers of NIFTY 50: A Day of Decline for Leading Stocks

India's renewable energy capacity addition doubled to 15 GW in Apr-Nov: Pralhad Joshi

India's renewable energy capacity addition doubled to 15 GW in Apr-Nov: Pralhad Joshi

Editorji Technologies Pvt. Ltd. © 2022 All Rights Reserved.